Mounjaro®
Starting from £179.99/mo
Start journey Learn moreGetting the most out of Wegovy comes down to a set of practical decisions you make alongside the medicine — protein intake, activity type, sleep, and how you handle the side-effect window. Wegovy (semaglutide) is a once-weekly prescription injection licensed in the UK for weight management in eligible adults; in the STEP 1 clinical trial, participants lost an average of around 15% of their body weight over 68 weeks alongside lifestyle changes, as published in the STEP 1 trial in the New England Journal of Medicine. That figure is an average — your result sits above or below it depending on factors you can meaningfully influence. These are prescription-only medicines; a clinician assesses your suitability before any treatment starts.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Wegovy does the appetite signalling; you still decide what goes on the plate. The most consistent finding across weight-management research is that protein intake strongly predicts how much of the weight lost is fat versus muscle. Aim for protein at every meal (eggs, fish, chicken, legumes, Greek yoghurt) particularly as portions shrink and overall calorie intake falls. Muscle tissue is metabolically expensive, which means preserving it keeps your resting calorie burn higher for the long term.
Fibre is the other variable most people underestimate. Vegetables, pulses and wholegrains slow digestion further, support the gut microbiome, and help you feel full on smaller volumes. Wegovy already slows gastric emptying; a fibre-rich meal pattern amplifies that signal. Highly processed foods tend to work in the opposite direction, easy to eat quickly, low saturation value, less helpful when you're trying to let the medicine do its job.
A quick check you can build into any day: before a meal, look at your plate and ask whether there is a clear protein source and at least one high-fibre element. That ten-second habit costs nothing and consistently nudges meals in the right direction. The weight-loss treatment overview has more on lifestyle support alongside medical treatment.
The research on GLP-1 medicines and exercise points in one consistent direction: resistance or strength-based activity protects lean mass during the weight-loss phase in a way that cardio alone does not. That does not mean abandoning walking or cycling (both are valuable for cardiovascular health and general energy expenditure) but adding two or three sessions of resistance work each week (bodyweight, bands, weights) gives your body a reason to hold onto muscle while shedding fat.
If you are new to structured exercise, start simply. A 20-minute bodyweight circuit three times a week is enough to generate a meaningful signal. Intensity matters less than consistency in the early months. As weight falls and energy often improves, increasing the load becomes more realistic.
Sleep is frequently left out of this conversation and should not be. Poor sleep raises ghrelin (the hunger hormone) and lowers leptin (the fullness hormone), directly working against what Wegovy is trying to achieve. Seven to nine hours is the NHS guidance range for adults. If sleep quality is genuinely poor, that is worth raising with your GP or prescriber, it is not a side issue. Our page on how long Wegovy takes to work is a question our prescribers hear regularly, and sleep is part of that answer.
Nausea is the most common reason people eat less during the early weeks on Wegovy, which sounds helpful until it means skipping meals and losing muscle rather than fat, or cutting out nutritious foods because they feel unappealing. Small, frequent meals tend to sit better than large ones during the adjustment period. Cold or room-temperature foods are often easier to tolerate than hot dishes when nausea is present. Staying well hydrated matters: semaglutide can reduce the sensation of thirst alongside appetite, and dehydration compounds GI discomfort.
The side-effect profile (nausea, constipation, occasional diarrhoea, reflux) is well documented in NHS guidance and typically peaks in the first weeks after a dose increase, then settles. The titration schedule is designed to minimise this window; moving through doses slowly is not a failure. If symptoms are severe or persistent, that is a conversation for your prescriber, not something to push through alone. The NHS patient information page on semaglutide sets out what to expect and when to seek advice.
One thing worth knowing: alcohol is calorically dense, can worsen nausea on semaglutide, and tends to disrupt sleep quality, all three of which pull against the outcomes you are working towards. Reducing intake during treatment is practical advice, not a rule, but most people find it makes the early weeks considerably more comfortable. If you want to get the most from your treatment, our guidance on how to maximise weight loss on Wegovy covers the clinical evidence in detail.
A plateau is not evidence that Wegovy has stopped working. It is a normal physiological response: as body weight falls, the body's total calorie requirement falls with it, meaning the same diet that produced a deficit at week four may produce a much smaller one at week twenty-four. This is biology, not a setback.
The practical response is a structured review rather than a dramatic change. Look first at protein and fibre intake, these are the easiest variables to let slip as appetite suppression becomes familiar. Review sleep and stress, both of which affect cortisol and fat storage independently of calorie intake. Consider whether resistance exercise has been consistent. If all of those are reasonable and weight has genuinely plateaued for six or more weeks, a dose review with your prescriber is the right next step, not a change you should make unilaterally.
Some people find that keeping a brief food and activity log for a week or two reveals where things have quietly drifted. It does not need to be a calorie-counting exercise; a simple pattern record is often enough to identify what has changed. Our guide to weight-loss stalls on Wegovy covers this in more depth, and what typical weight loss on Wegovy looks like gives useful context on the expected trajectory. If you are curious about how long it takes to see weight loss on Wegovy, that page explains what the evidence says about timing across the treatment period. People often ask about how much weight loss is achievable on Wegovy at its peak, and that page sets out the clinical data honestly. For any questions specific to your treatment, speaking to your prescriber is always the right starting point, start a free consultation with our clinical team to get answers tailored to your situation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.